p53 regulates the proliferation, differentiation and spontaneous transformation of mesenchymal stem cells
- PMID: 19686735
- DOI: 10.1016/j.yexcr.2009.08.004
p53 regulates the proliferation, differentiation and spontaneous transformation of mesenchymal stem cells
Abstract
Mesenchymal stem cells (MSC) have been extensively studied and gained wide popularity due to their therapeutic potential. Spontaneous transformation of MSC, from both human and murine origin, has been reported in many studies. MSC transformation depends on the culture conditions, the origin of the cells and the time on culture; however, the precise biological characteristics involved in this process have not been fully defined yet. In this study, we investigated the role of p53 in the biology and transformation of murine bone marrow (BM)-derived MSC. We demonstrate that the MSC derived from p53KO mice showed an augmented proliferation rate, a shorter doubling time and also morphologic and phenotypic changes, as compared to MSC derived from wild-type animals. Furthermore, the MSC devoid of p53 had an increased number of cells able to generate colonies. In addition, not only proliferation but also MSC differentiation is controlled by p53 since its absence modifies the speed of the process. Moreover, genomic instability, changes in the expression of c-myc and anchorage independent growth were also observed in p53KO MSC. In addition, the absence of p53 implicates the spontaneous transformation of MSC in long-term cultures. Our results reveal that p53 plays a central role in the biology of MSC.
Similar articles
-
Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo.Cancer Res. 2010 May 15;70(10):4185-94. doi: 10.1158/0008-5472.CAN-09-4640. Epub 2010 May 4. Cancer Res. 2010. PMID: 20442289
-
RB and RB2/p130 genes demonstrate both specific and overlapping functions during the early steps of in vitro neural differentiation of marrow stromal stem cells.Cell Death Differ. 2005 Jan;12(1):65-77. doi: 10.1038/sj.cdd.4401499. Cell Death Differ. 2005. PMID: 15459751
-
Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials.Haematologica. 2006 Aug;91(8):1017-26. Epub 2006 Jul 25. Haematologica. 2006. PMID: 16870554
-
Mesenchymal stem cells.Ann Med. 2005;37(7):469-79. doi: 10.1080/07853890500371957. Ann Med. 2005. PMID: 16278160 Review.
-
Controversial issue: is it safe to employ mesenchymal stem cells in cell-based therapies?Exp Gerontol. 2008 Nov;43(11):1018-23. doi: 10.1016/j.exger.2008.07.004. Epub 2008 Jul 24. Exp Gerontol. 2008. PMID: 18694815 Review.
Cited by
-
Bone marrow derivation of interstitial cells of cajal in small intestine following intestinal injury.J Biomed Biotechnol. 2010;2010:164986. doi: 10.1155/2010/164986. Epub 2010 Apr 12. J Biomed Biotechnol. 2010. PMID: 20396598 Free PMC article.
-
Eldecalcitol prevented OVX-induced osteoporosis through inhibiting BMSCs senescence by regulating the SIRT1-Nrf2 signal.Front Pharmacol. 2023 Mar 3;14:1067085. doi: 10.3389/fphar.2023.1067085. eCollection 2023. Front Pharmacol. 2023. PMID: 36937895 Free PMC article.
-
Basal p53 expression is indispensable for mesenchymal stem cell integrity.Cell Death Differ. 2018 Mar;25(4):679-692. doi: 10.1038/s41418-017-0004-4. Epub 2018 Jan 8. Cell Death Differ. 2018. PMID: 29311623 Free PMC article.
-
FOXP1 drives osteosarcoma development by repressing P21 and RB transcription downstream of P53.Oncogene. 2021 Apr;40(15):2785-2802. doi: 10.1038/s41388-021-01742-4. Epub 2021 Mar 14. Oncogene. 2021. PMID: 33716296
-
The Role of Autophagy in the Maintenance of Stemness and Differentiation of Mesenchymal Stem Cells.Stem Cell Rev Rep. 2016 Dec;12(6):621-633. doi: 10.1007/s12015-016-9690-4. Stem Cell Rev Rep. 2016. PMID: 27696271 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous